Bristol-Myers Squibb Reports - Industry Research
Reports Featuring Bristol-Myers Squibb
Drug Discovery Market
The Drug Discovery Market size is estimated at USD 100.10 billion in 2024, and is expected to reach USD 137.72 billion by 2029, growing at a CAGR of 6.59% during the forecast period (2024-2029).
Global Pancreatic Cancer Therapeutics and Diagnostics Market
The Global Pancreatic Cancer Therapeutics and Diagnostics Market size is estimated at USD 4.56 billion in 2024, and is expected to reach USD 6.55 billion by 2029, growing at a CAGR of 7.52% during the forecast period (2024-2029).
Biopharmaceuticals Market
The Biopharmaceuticals Market size is estimated at USD 516.79 billion in 2024, and is expected to reach USD 761.80 billion by 2029, growing at a CAGR of 8.07% during the forecast period (2024-2029).
Atopic Dermatitis Market
The Atopic Dermatitis Market size is estimated at USD 10.06 billion in 2024, and is expected to reach USD 14.23 billion by 2029, growing at a CAGR of 7.18% during the forecast period (2024-2029).
Cancer Cachexia Market
The Cancer Cachexia Market size is estimated at USD 2.72 billion in 2024, and is expected to reach USD 3.34 billion by 2029, growing at a CAGR of 4.19% during the forecast period (2024-2029).
Peptide Therapeutics Market
The peptide therapeutics market is expected to register a CAGR of 9.66% over the forecast period.
Global Anticoagulants Market
The Anticoagulants Market is expected to register a CAGR of 9.41% during the forecast period (2022-2027).
Acute Myeloid Leukemia Market
The Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 10.15% during the forecast period (2024-2029).
Global Orphan Drugs Market
The Global Orphan Drugs Market size is estimated at USD 217.35 billion in 2024, and is expected to reach USD 294.17 billion by 2029, growing at a CAGR of 6.24% during the forecast period (2024-2029).
Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market
The Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market size is estimated at USD 244.60 million in 2024, and is expected to reach USD 357.73 million by 2029, growing at a CAGR of 7.90% during the forecast period (2024-2029).
Alzheimer's Disease Diagnostics and Therapeutics Market
The Alzheimer's Disease Diagnostics and Therapeutics Market size is estimated at USD 7.65 billion in 2024, and is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029).
North America Uterine Cancer Diagnostics & Treatment Market
The North America Uterine Cancer Diagnostics & Treatment Market size is estimated at USD 9.57 billion in 2024, and is expected to reach USD 11.77 billion by 2029, growing at a CAGR of 4.22% during the forecast period (2024-2029).
Asia-Pacific Cancer Vaccines Market
The Asia-Pacific Cancer Vaccines Market size is estimated at USD 2.34 billion in 2024, and is expected to reach USD 4.06 billion by 2029, growing at a CAGR of 11.55% during the forecast period (2024-2029).
North America Biguanide Market
The North America Biguanide Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 2.59% during the forecast period (2024-2029).
Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market
The Sodium-dependent Glucose Co-transporter 2 Market size is estimated at USD 11.42 billion in 2024, and is expected to reach USD 17.32 billion by 2029, growing at a CAGR of 8.68% during the forecast period (2024-2029).
Albumin Market
The albumin market is expected to register a CAGR of nearly 5.20% during the forecast period.
Inflammatory Bowel Disease (IBD) Therapeutics Market
The Inflammatory Bowel Disease Therapeutics Market size in terms of Equal-5.15 is expected to grow from USD 24.46 billion in 2024 to USD 31.43 billion by 2029, at a CAGR of 5.15% during the forecast period (2024-2029).
Fibrotic Disease Treatment Market
The fibrotic disease treatment market is expected to grow at a registered CAGR of 7.2% over the forecast period.
Hepatitis C Market
The hepatitis C market is poised to register a CAGR of 12.82% over the forecast period.
Oral Cancer Therapy Market
The Oral Cancer Therapy Market size is estimated at USD 2.05 billion in 2024, and is expected to reach USD 2.65 billion by 2028, growing at a CAGR of 5.32% during the forecast period (2024-2028).
Anal Cancer Market
The Anal Cancer Market size is estimated at USD 0.91 billion in 2024, and is expected to reach USD 1.26 billion by 2029, growing at a CAGR of 6.60% during the forecast period (2024-2029).
Lung Cancer Therapeutics Market
The lung cancer therapeutics market is projected to register a CAGR of 8.7% during the forecast period.
Global Rheumatoid Arthritis Drugs Market
The rheumatoid arthritis drugs market is poised to grow at a CAGR of 5.6% during the forecast period (2022-2027).
Anti-Viral Therapeutics Market
The anti-viral therapeutics market is expected to register a CAGR of 4.58% over the forecast period.
Unresectable Hepatocellular Carcinoma Market
The Unresectable Hepatocellular Carcinoma Market size is estimated at USD 2.01 billion in 2024, and is expected to reach USD 3.07 billion by 2029, growing at a CAGR of 8.84% during the forecast period (2024-2029).
Global Oncology Clinical Trials Market
The global oncology clinical trials market is expected to witness a CAGR of 5.4% during the forecast period (2022-2027).
Global Advanced Therapy Medicinal Products (ATMPs) Market
The advanced therapy medicinal products (ATMPs) market is projected to register a CAGR of 13% during the forecast period.
Global Specialty Pharmaceuticals Market
The specialty pharmaceuticals market is expected to grow at a significant CAGR of 35.4% during the study period (2022-2027).
Global T-Cell Lymphoma Market
The Global T-Cell Lymphoma Market size is estimated at USD 2.21 billion in 2024, and is expected to reach USD 3.05 billion by 2029, growing at a CAGR of 6.66% during the forecast period (2024-2029).
Global Nasopharyngeal Cancer Market
Over the next few years, the market for nasopharyngeal cancer is expected to grow at a CAGR of 2.7%.
Europe Cancer Vaccines Market
The Europe Cancer Vaccines Market is expected to grow with a CAGR of 10.21% in the forecast period.
Global Pediatric Clinical Trials Market
The Pediatric Clinical Trials Market was estimated to grow at a CAGR of 14.5% during the forecast period.
Global Leukemia Therapeutics Market
The Leukemia Therapeutics Market is expected to register a CAGR of 5.5% over the forecast period.
Healthcare Nanotechnology (Nanomedicine) Market
The healthcare nanotechnology (nanomedicine) market is expected to register a CAGR of nearly 11.9% during the forecast period.
Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market
The Middle East and Africa kidney cancer therapeutics and diagnostics market is projected to grow at a CAGR of 5.2% over the forecast period.
Europe Cancer Therapeutics Market
The Europe Cancer Therapeutics Market size is estimated at USD 58.32 billion in 2024, and is expected to reach USD 75.79 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029).
Global Melanoma Diagnostics and Therapeutics Market
The Melanoma Diagnostics and Therapeutics market is expected to register a CAGR of 15.1% over the forecast period, 2022-2027.
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Market
The Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market size is estimated at USD 1.82 billion in 2024, and is expected to reach USD 2.72 billion by 2029, growing at a CAGR of 8.35% during the forecast period (2024-2029).
Europe Sodium-dependent Glucose Cotransporter 2 Market
The Europe Sodium-dependent Glucose Cotransporter 2 Market size is estimated at USD 1.30 billion in 2024, and is expected to reach USD 2.02 billion by 2029, growing at a CAGR of 9.10% during the forecast period (2024-2029).
Global Skin Cancer Diagnostics and Therapeutics Market
The Global Skin Cancer Diagnostics and Therapeutics Market size is estimated at USD 13.82 billion in 2024, and is expected to reach USD 17.82 billion by 2029, growing at a CAGR of 5.21% during the forecast period (2024-2029).
Adult Malignant Glioma Therapeutics Market
The adult malignant glioma therapeutics market is projected to register a CAGR of 9.6% during the forecast period.
Global T-cell Acute Lymphoblastic Leukemia Treatment Market
The T-cell Acute Lymphoblastic Leukemia Treatment Market is anticipated to grow with a CAGR of nearly 7.8% over the forecast period.
Chronic Myelogenous Leukemia Treatment Market
The chronic myelogenous leukemia (CML) treatment market is expected to register a CAGR of 5.3% over the forecast period.
Antithrombotic Drugs Market
The antithrombotic drug market is projected to register a CAGR of 7.5% during the forecast period.
Hepatitis Therapeutics Market
During the time frame of the forecast, the hepatitis therapeutics market is expected to grow at a CAGR of 3.5%.
PD-1 And PD-L1 Inhibitors Market
The PD-1 and PD-L1 inhibitors market is estimated at USD 45.80 billion in 2023.
Myelodysplastic Syndrome (MDS) Treatment Market
The myelodysplastic syndrome (MDS) treatment market is projected to register a CAGR of 6.5% during the forecast period, 2022-2027.
Global Myeloproliferative Disorders (MPD) Treatment Market
The myeloproliferative disorders (MPD) treatment market is expected to register a CAGR of 4.9% over the forecast period.
Immune Checkpoint Inhibitors Market
The immune checkpoint inhibitors market is anticipated to register a CAGR of 18% during the forecast period.
Non-Small Cell Lung Cancer (NSCLC) Market
The non-small cell lung cancer (NSCLC) market is expected to register a CAGR of 9.5% during the forecast period.
Global Stroke Therapeutics Market
The stroke therapeutics market is projected to register a CAGR of 4.5% during the forecast period, 2022-2027.
Global Addison's Disease Treatment Market
Addison's Disease Treatment market is projected to register a CAGR of 4.1% during the forecast period (2022 - 2027).
Global Colorectal Cancer Therapeutics Market
The colorectal cancer therapeutics market is projected to register a CAGR of 6.1% during the forecast period (2022-2027).
Rare Disease Treatment Market
The Rare Disease Treatment Market size is estimated at USD 216.65 billion in 2024, and is expected to reach USD 380.62 billion by 2029, growing at a CAGR of 11.93% during the forecast period (2024-2029).
Europe Kidney Cancer Therapeutics & Diagnostics Market
The Europe Kidney Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 5.7% during the forecast period.
Anti-retroviral Drugs Market
The anti-retroviral drugs market is estimated to register a CAGR of 4.0% over the forecast period.
Acute Lymphoblastic Leukemia Therapeutics Market
One of the major factors responsible for the growth of this market includes the rising occurrence of acute lymphoblastic leukemia (ALL) globally.
MEA Cancer Vaccines Market
The Middle East and Africa cancer vaccine market is expected to register a CAGR of 9.6% during the forecast period.
Kidney Cancer Therapeutics and Diagnostics Market
The Kidney Cancer Therapeutics and Diagnostics Market size is estimated at USD 6.92 billion in 2024, and is expected to reach USD 8.78 billion by 2029, growing at a CAGR of 4.86% during the forecast period (2024-2029).
Global Hodgkin Lymphoma Treatment Market
The Hodgkin lymphoma (HL) treatment market is expected to register a CAGR of 12.5% during the forecast period.
South America Bladder Cancer Therapeutics and Diagnostics Market
The South America Bladder Cancer Therapeutics and Diagnostics Market is projected to record a CAGR of 3.0% over the forecast period.
MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market
The MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market size is estimated at USD 165.5 million in 2024, and is expected to reach USD 256.40 million by 2029, growing at a CAGR of 9.15% during the forecast period (2024-2029).
Biguanides Market
The Biguanides Market size is estimated at USD 5.20 billion in 2024, and is expected to reach USD 5.76 billion by 2029, growing at a CAGR of 2.07% during the forecast period (2024-2029).
Psoriatic Arthritis Therapeutics Market
The psoriatic arthritis therapeutic market is expected to register a CAGR of 6.65% over the forecast period.
Kaposi Sarcoma Market
The Kaposi sarcoma market is poised to grow at a CAGR of 7% during the forecast period.
Cryptococcosis Therapeutics Market
Cryptococcosis is a fungal infection which is caused by Cryptococcus neoformans and Cryptococcus gattii which primarily affects the central nervous system and the lungs.
Global Hematologic Malignancies Treatment Market
The Global Hematologic Malignancies Treatment Market size is estimated at USD 67.23 billion in 2024, and is expected to reach USD 97.73 billion by 2029, growing at a CAGR of 7.77% during the forecast period (2024-2029).
Global Immunosuppressant Drugs Market
The immunosuppressant drugs market is expected to register a CAGR of 4.6% during the forecast period.
Graft Versus Host Disease Treatment Market
The Graft Versus Host disease treatment market is projected to register a CAGR of 8.4% during the forecast period.
Multiple Myeloma Market
The multiple myeloma market is expected to witness a CAGR of 6% over the forecast period.
Global Lenalidomide Market
The Lenalidomide market studied is expected to witness an estimated CAGR of 5.0% over the forecast period (2022-2027).
Global Targeted Cancer Therapy Market
The targeted cancer therapy market is projected to record a CAGR of 7.1% during the forecast period.
Global Minimal Residual Disease Market
The Global Minimal Residual Disease Market size is estimated at USD 1.9 billion in 2024, and is expected to reach USD 3.49 billion by 2029, growing at a CAGR of 12.88% during the forecast period (2024-2029).
Global CAR T-Cell Therapy Market
The CAR T-cell therapy market is expected to register a CAGR of more than 30% over the forecast period.
Next-Generation Antibody Therapeutics Market
Over the next few years, the market for next-generation antibody therapeutics is expected to register a CAGR of 12.1%.
Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market
Asia-Pacific Bladder Cancer Therapeutics and Diagnostics market is expected to register a CAGR of 5% during the forecast period, owing to increasing burden of bladder cancer and new diagnosis & treatments coming up in the market.
Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market
The market studied is majorly driven by the factors such as the increasing prevalence of pancreatic cancer, increasing demand for diagnostic tests and treatment of this disease.
North America Cancer Vaccines Market
The North America Cancer Vaccines Market is expected to grow with a CAGR of 12.2% in the forecast period.
South America America Pancreatic Cancer Therapeutics and Diagnostics Market
The market studied is majorly driven by factors, such as the increasing prevalence of pancreatic cancer and the increasing demand for diagnostic tests and treatments of this disease.
Latin America Bladder Cancer Therapeutics & Diagnostics Market
Based on the data from the International Agency for Research on Cancer, bladder cancer is the 6th most commonly diagnosed cancer of males and the 9th leading cause of cancer deaths worldwide.
APAC Ovarian Cancer Diagnostics & Therapeutics Market Size
The Asia-Pacific ovarian cancer diagnostics and therapeutics market is expected to register a CAGR of 15.1% during the forecast period.
South America Kidney Cancer Therapeutics & Diagnostics Market
Kidney cancer is a disease that starts in the kidneys.
North America Stem Cell Market
The North American stem cell market is expected to witness a CAGR of 9.5% during the forecast period.
MEA Bladder Cancer Therapeutics & Diagnostics Market
The bladder cancer therapeutics and diagnostics market will witness rapid growth due to the increasing awareness about bladder diseases and available therapies, along with growing innovation in drug development.
Skin Cancer Therapeutics Market
The Skin Cancer Therapeutics Market is poised to grow at a CAGR of 10.1% over the forecast period.
Latin America Liver Cancer Treatment Market
The Latin American liver cancer treatment market is expected to register a CAGR of nearly 7.9% during the forecast period.
Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The Asia-Pacific Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 4.30 billion in 2024, and is expected to reach USD 5.18 billion by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).
Europe Biguanide Market
The Europe Biguanide Market size is estimated at USD 1.25 billion in 2024, and is expected to reach USD 1.33 billion by 2029, growing at a CAGR of 1.27% during the forecast period (2024-2029).
Middle East and Africa Biguanide Market
The Middle East and Africa Biguanide Market size is estimated at USD 311.96 million in 2024, and is expected to reach USD 370.86 million by 2029, growing at a CAGR of 3.52% during the forecast period (2024-2029).
Global Urothelial Cancer Drugs Market
The urothelial cancer drugs market studied is projected to register a CAGR of 15.5% over the forecast period.
Organ Transplant Immunosuppressant Drugs Market
The organ transplant immunosuppressant drugs market is expected to register a CAGR of 3.5% during the forecast period.
Prophylactic HIV Drugs Market
The prophylactic human immunodeficiency virus (HIV) drug market is expected to register a CAGR of 4.1% during the forecast period.
Triamcinolone Ointment Chlorofluorocarbons Market
Skin disease is one of the leading causes of the increasing global disease burden, affecting millions of people worldwide.
Global Metastatic Cancer Treatment Market
The metastatic cancer treatment market is expected to register a CAGR of 8.1% over the forecast period, 2022-2027.
APAC Biguanide Market
The APAC Biguanide Market size is estimated at USD 1.97 billion in 2024, and is expected to reach USD 2.17 billion by 2029, growing at a CAGR of 2% during the forecast period (2024-2029).
Latin America Biguanide Market
The Latin America Biguanide Market size is estimated at USD 386.66 million in 2024, and is expected to reach USD 443.91 million by 2029, growing at a CAGR of 2.80% during the forecast period (2024-2029).
Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market
The Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market size is estimated at USD 0.3 billion in current year, and is expected to reach USD 0.5 billion by forecast period, growing at a CAGR of 9% during the forecast period.
Head and Neck Cancer Therapeutics Market
The Head and Neck Cancer Therapeutics Market is expected to register a CAGR of 9% over the forecast period.
Next-Generation Immunology Drugs Market
The Next-Generation Immunology Drugs Market is expected to register a CAGR of 6.1% over the forecast period.
Other Reports Covering Bristol-Myers Squibb
Biotechnology
- Biopharmaceuticals Market
- Blood Preparation Market
- Drug Discovery Market
- Global CAR T-Cell Therapy Market
- Global Monoclonal Antibodies Market
- Global Oncology Clinical Trials Market
- Global Pediatric Clinical Trials Market
- Healthcare Nanotechnology (Nanomedicine) Market
- Next-Generation Antibody Therapeutics Market
- Next-Generation Immunology Drugs Market
- North America Stem Cell Market
Device Drug Combination
- Alzheimer's Disease Diagnostics and Therapeutics Market
- Androgen Deprivation Therapy Market
- APAC Ovarian Cancer Diagnostics & Therapeutics Market Size
- Asia Pacific Liver Cancer Market
- Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market
- Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market
- Canada Diabetes Care Drugs And Devices Market
- Chronic Kidney Disease Market
- Europe Bladder Cancer Therapeutics and Diagnostics Market
- Europe Kidney Cancer Therapeutics & Diagnostics Market
- Europe Ovarian Cancer Diagnostics and Therapeutics Market
- Global Bladder Cancer Therapeutics and Diagnostics Market
- Global Cervical Cancer Diagnostics and Therapeutics Market
- Global Melanoma Diagnostics and Therapeutics Market
- Global Nanotechnology Drug Delivery Market
- Global Pancreatic Cancer Therapeutics and Diagnostics Market
- Global Skin Cancer Diagnostics and Therapeutics Market
- Graft Versus Host Disease Treatment Market
- Hepatitis C Market
- Indonesia Oral Anti-Diabetic Drug Market
- Kidney Cancer Therapeutics and Diagnostics Market
- MEA Bladder Cancer Therapeutics & Diagnostics Market
- Middle East & Africa Ovarian Cancer Diagnostics And Therapeutics Market
- Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market
- New Zealand Insulin Drugs and Devices Market
- North America Bladder Cancer Therapeutics and Diagnostics Market
- North America Uterine Cancer Diagnostics & Treatment Market
- Ovarian Cancer Diagnostics and Therapeutics Market
- Philippines Oral Anti-Diabetic Drug Market
- Skin Cancer Therapeutics Market
- South Africa Oral Antidiabetic Drug Market
- South America America Pancreatic Cancer Therapeutics and Diagnostics Market
- South America Bladder Cancer Therapeutics and Diagnostics Market
- South America Kidney Cancer Therapeutics & Diagnostics Market
- South America Ovarian Cancer Diagnostics and Therapeutics Market
- Thailand Oral Antidiabetic Drug Market
- Type 2 Diabetes Drugs And Devices Market
- Vietnam Insulin Drug And Delivery Device Market
- Vietnam Oral Anti-Diabetic Drug Market
Medical Devices
- Brazil Oral Anti-Diabetic Drug Market
- France Oral Anti-Diabetic Drug Market
- Global Acute Otitis Media Treatment Market
- Global Minimal Residual Disease Market
- India Insulin Drug And Delivery Device Market
- IV Poles Market
- Novel Drug Delivery Systems (NDDS) Market
- South Korea Oral Anti-Diabetic Drug Market
Pharmaceuticals
- Immunotherapy Drugs Market
- Acute Lymphoblastic Leukemia Therapeutics Market
- Acute Myeloid Leukemia Market
- Adult Malignant Glioma Therapeutics Market
- Albumin Market
- Anal Cancer Market
- Anti-infective Drugs Market
- Anti-obesity Drugs Market
- Anti-retroviral Drugs Market
- Anti-Viral Therapeutics Market
- Antithrombotic Drugs Market
- APAC Biguanide Market
- Asia-Pacific Cancer Therapy Market
- Asia-Pacific Cancer Vaccines Market
- Asia-Pacific Diabetes Care Drugs Market
- Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Asia-Pacific Oral Anti-Diabetic Drug Market
- Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Market
- Atopic Dermatitis Market
- Australia Diabetes Care Drugs Market
- Belgium Pharmaceutical Market
- Biguanides Market
- Brain Tumor Therapeutics Market
- Brazil Diabetes Drugs Market
- Brazil Oral Anti-Diabetic Drug Market
- Breast Cancer Therapy Market
- Canada Pharmaceutical Market
- Cancer Cachexia Market
- Cancer Immunotherapy Market
- Cancer Vaccines Market
- China Diabetes Care Drugs Market
- Chronic Myelogenous Leukemia Treatment Market
- Coronary Artery Disease Therapeutics Market
- Cryptococcosis Therapeutics Market
- Cutaneous T-cell Lymphoma Market
- Dermatological Therapeutics Market
- Diabetes Care Drugs Market
- Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Egypt Diabetes Drugs Market
- Europe Biguanide Market
- Europe Cancer Therapeutics Market
- Europe Cancer Vaccines Market
- Europe Diabetes Drugs Market
- Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Europe Monoclonal Antibodies Market
- Europe Oral Anti-Diabetic Drug Market
- Europe Over-the-counter (OTC) Drugs Market
- Europe Sodium-dependent Glucose Cotransporter 2 Market
- Fibrotic Disease Treatment Market
- Finland Pharmaceutical Market
- France Diabetes Drugs Market
- Gastric Cancer Therapy Market
- Germany Diabetes Drugs Market
- Germany OTC Drug Market
- Glioblastoma Multiforme Treatment Market
- Global Acute Agitation and Aggression Treatment Market
- Global Adalimumab Drugs Market
- Global Addison's Disease Treatment Market
- Global Advanced Therapy Medicinal Products (ATMPs) Market
- Global Aminoglycosides Market
- Global Anticoagulants Market
- Global Anxiety Disorders and Depression Treatment Market
- Global Autoimmune Treatment Market
- Global Cancer Monoclonal Antibodies Market
- Global Cancer Therapy Market
- Global Cell Based Immunotherapy Market
- Global Cephalosporin Drugs Market
- Global Colorectal Cancer Therapeutics Market
- Global Endometrial Cancer Market
- Global Geriatric Medicines Market
- Global Hematologic Malignancies Treatment Market
- Global HER-2 Negative Breast Cancer Market
- Global Hodgkin Lymphoma Treatment Market
- Global Hypertrophic Cardiomyopathy Therapeutics Market
- Global Immunomodulators Market
- Global Immunosuppressant Drugs Market
- Global Leukemia Therapeutics Market
- Global Lipid Regulators Market
- Global Metastatic Cancer Treatment Market
- Global Metastatic Melanoma Drugs Market
- Global Myeloproliferative Disorders (MPD) Treatment Market
- Global Nasopharyngeal Cancer Market
- Global Neuroendocrine Tumor Treatment Market
- Global Orphan Drugs Market
- Global Polycystic Ovarian Syndrome Treatment Market
- Global Pulmonary Arterial Hypertension Market
- Global Rheumatoid Arthritis Drugs Market
- Global Schizophrenia Drugs Market
- Global Specialty Pharmaceuticals Market
- Global Stroke Therapeutics Market
- Global T-cell Acute Lymphoblastic Leukemia Treatment Market
- Global T-Cell Lymphoma Market
- Global Targeted Cancer Therapy Market
- Global Treatment-Resistant Depression Market
- Global Urothelial Cancer Drugs Market
- Gram-positive Bacterial Infections Market
- Head and Neck Cancer Therapeutics Market
- Hepatitis Therapeutics Market
- Idiopathic Pulmonary Fibrosis Market
- Immune Checkpoint Inhibitors Market
- India Diabetes Care Drugs Market
- India Oral Anti-Diabetic Drug Market
- Indonesia Diabetes Care Drugs Market
- Infectious Enteritis Treatment Market
- Inflammatory Bowel Disease (IBD) Therapeutics Market
- Iran Diabetes Care Drugs Market
- Italy Diabetes Drugs Market
- Italy Oral Anti-Diabetic Drug Market
- Japan Diabetes Drugs Market
- Japan Oral Anti-Diabetic Drug Market
- Kaposi Sarcoma Market
- Korea Pharmaceutical Market
- Latin America Biguanide Market
- Latin America Bladder Cancer Therapeutics & Diagnostics Market
- Latin America Diabetes Care Drugs Market
- Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Latin America Liver Cancer Treatment Market
- Latin America Oral Anti-Diabetic Drug Market
- Latin America Sodium-Glucose Cotransport-2 (SGLT-2) Inhibitor Market
- Liver Cancer Therapeutics Market
- Liver Diseases Therapeutics Market
- Lung Cancer Therapeutics Market
- Malaysia Diabetes Care Drugs Market
- Malaysia Oral Anti-Diabetic Drug Market
- MEA Cancer Vaccines Market
- MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market
- Meglitinide Market
- Menopausal Hot Flashes Market
- Mexico Diabetes Drugs Market
- Mexico Oral Anti-Diabetic Drug Market
- Middle East and Africa Biguanide Market
- Middle East and Africa Diabetes Drugs Market
- Middle East And Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Multiple Myeloma Market
- Multiple Sclerosis Therapeutics Market
- Myelodysplastic Syndrome (MDS) Treatment Market
- New Zealand Diabetes Drugs Market
- New Zealand Oral Anti-Diabetic Drug Market
- Non-Hodgkin Lymphoma Therapeutics Market
- Non-Small Cell Lung Cancer (NSCLC) Market
- North America Biguanide Market
- North America Cancer Therapy Market
- North America Cancer Vaccines Market
- North America Diabetes Drugs Market
- North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- North America Oral Anti-Diabetic Drug Market
- Norway Pharmaceutical Market
- Oman Diabetes Drugs Market
- Oral Anti-Diabetic Drugs Market
- Oral Cancer Therapy Market
- Organ Transplant Immunosuppressant Drugs Market
- PD-1 And PD-L1 Inhibitors Market
- Pelvic Inflammatory Disease Therapeutics Market
- Peptide and Anticoagulant Drugs Market
- Peptide Therapeutics Market
- Philippines Diabetes Care Drugs Market
- Precision Medicine Market
- Prophylactic HIV Drugs Market
- Pseudomonas Aeruginosa Infection Treatment Market
- Psoriatic Arthritis Therapeutics Market
- Rare Disease Treatment Market
- Retinoblastoma Treatment Market
- Russia Diabetes Drugs Market
- Saudi Arabia Diabetes Drugs Market
- Sickle Cell Treatment Market
- Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market
- Solid Tumor Therapeutics Market
- South Africa Diabetes Drugs Market
- South Korea Diabetes Drugs Market
- Spain Diabetes Care Drugs Market
- Spain Over-the-counter (OTC) Drugs Market
- Systemic Lupus Erythematosus Market
- Thailand Diabetes Care Drugs Market
- Thrombosis Drugs Market
- Thyroid Cancer Therapeutics Market
- TNF Inhibitors Market
- Traveler's Diarrhea Treatment Market
- Triamcinolone Ointment Chlorofluorocarbons Market
- Tyrosine Kinase Inhibitors Market
- Ulcerative Colitis Market
- United Kingdom (UK) Diabetes Drugs Market
- United States Active Pharmaceutical Ingredients (API) Market
- Unresectable Hepatocellular Carcinoma Market
- Urinary Tract Infection Therapeutics Market
- US Diabetes Care Drugs Market
- Vietnam Diabetes Care Drugs Market
Industries Bristol-Myers Squibb Operates Within:
Oncology Drugs Companies
- Europe Oncology Drugs Companies
- Middle East and Africa Oncology Drugs Companies
- South America Oncology Drugs Companies
- Asia Oncology Drugs Companies
- Europe Oncology Drugs Companies
- Middle East and Africa Oncology Drugs Companies
- North America Oncology Drugs Companies
- South America Oncology Drugs Companies
